Rohini Chavare: PGT Technology Enhancements Driving IVF Success Rates
Rohini Chavare, Assistant Manager at Marketsand Markets, shared a post on LinkedIn:
“Preimplantation Genetic Testing (PGT): Advancing Precision in IVF Embryo Selection
Download PDF Brochure.
Preimplantation Genetic Testing (PGT) is transforming assisted reproduction by enabling early detection of genetic abnormalities before embryo implantation. By combining advanced technologies like NGS, PCR, SNP analysis, and Array CGH, PGT helps improve IVF success rates and supports informed reproductive decisions.
As genetic screening technologies continue to evolve, PGT is playing a critical role in reducing inherited disease risk and improving patient outcomes in reproductive medicine.
The preimplantation genetic testing market is projected to reach USD 1,135.0 million by 2030 from USD 690.2 million in 2025, at a CAGR of 10.5% from 2025 to 2030.
The procedure type segment comprises preimplantation genetic screening and preimplantation genetic diagnosis. Preimplantation genetic screening is highly demanded with the rising demand for assisted reproductive technologies.
Key technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH). NGS dominates the market with increasing use of these systems in fertility clinics and research institutes for preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD).
Major market players have adopted organic and inorganic strategies, including product launches, partnerships, and investments. For instance, in July 2023, Thermo Fisher Scientific Inc. (US) launched two new NGS-based test kits to support preimplantation genetic testing for aneuploidy (PGT-A), commonly used in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 3, 2026, 12:57Sergei Gorlovetsky: The Invisible Work Breaking Fertility Clinics
-
Apr 3, 2026, 12:50Ting Yuan: Rethinking Oocyte Quality Through Reproducible Patterns
-
Apr 3, 2026, 12:36Asma Khalil: An Incredibly Powerful Podcast Brings Attention to Women’s Fertility Challenges
-
Apr 3, 2026, 12:29Angela Koech: Every 30 Seconds, Africa Loses a Baby to a Preventable Stillbirth
-
Apr 3, 2026, 12:17Sergei Gorlovetsky: AI Support Expands Guidance for IVF Patients at Home
-
Apr 3, 2026, 12:06Thin Womb Lining Doesn’t Have to End Your IVF Dreams – Fertility Plus
-
Apr 3, 2026, 12:04Updated NICE IVF Guidance Contrasts with Declining NHS Support – HFEA
-
Apr 3, 2026, 11:59IVF Remains Safe for Women With a History of Cancer – ESHRE
-
Apr 3, 2026, 11:56Vitamin D Binding Protein and Reproductive Outcomes – Fertility and Sterility
